2002臺灣消化醫學雜誌Requires access

Pulmonary Embolism after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Report of a Case

Wei-Hsu Ko, Kuo‐Ching Yang, Ta-Nien Lu, Kou‐Gi Shyu, Yeh-You Shen

Open publisher page 0 citations

Abstract

Pulmonary embolism is an important cause of morbidity and mortality. Some patients develop pulmonary embolism after transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma, because the Lipiodol oil embolizes to the pulmonary arterial circulation. We reported one patient with hepatocellular carcinoma complicated by cardio-pulmonary distress secondary to TA CE. The clinical history, laboratory data and image study all supported the diagnosis of pulmonary embolism. Definite diagnosis was confirmed by scintigraphy and pulmonary angiography. This patient fully recovered from the respiratory event after installation of heparin and other supportive care. The clinician must be aware of this potentially fatal complication of TACE. Prompt diagnosis is necessary for optimal management.

About this research paper

What this paper is about

Pulmonary embolism is an important cause of morbidity and mortality. Some patients develop pulmonary embolism after transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma, because the Lipiodol oil embolizes to the pulmonary arterial circulation. We reported one patient with hepatocellular carcinoma complicated by cardio-pulmonary distress secondary to TA CE. The clinical history, laboratory data and image study all supported the diagnosis of pulmonary embolism. Definite diagnosis was confirmed by scintigraphy and pulmonary angiography. This patient fully recovered from the respiratory event after installation of heparin and other supportive care. The clinician must be aware of this potentially fatal complication of TACE. Prompt diagnosis is necessary for optimal management.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Pulmonary embolism is an important cause of morbidity and mortality. Some patients develop pulmonary embolism after transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma, because the Lipiodol oil embolizes to the pulmonary arterial circulation. We reported one patient with hepatocellular carcinoma complicated by cardio-pulmonary distress secondary to TA CE. The clinical history, laboratory data and image study all supported the diagnosis of pulmonary embolism. Definite diagnosis was confirmed by scintigraphy and pulmonary angiography. This patient fully recovered from the respiratory event after installation of heparin and other supportive care. The clinician must be aware of this potentially fatal complication of TACE. Prompt diagnosis is necessary for optimal management.

Key concepts: Medicine, Pulmonary embolism, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Radiology, Pulmonary angiography, Lipiodol, Angiography

Related papers

Back to paper searchBrowse research topicsOriginal source
Pulmonary Embolism after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Report of a Case — Research Paper | ScholarLens